Latest filing published 05 Sept 2017 for ALBANY MOLECULAR RESEARCH INC, €125k.
Insider track record
Kenneth Paul Hagen: trading record in brief
All filings by Kenneth Paul Hagen on record concern Albany Molecular Research Inc. We count 3 filings; the first trade dates from 15 June 2016 and the latest from 31 August 2017.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
On 5 September 2017 came the latest disclosure, a transaction for €125k in Albany Molecular Research Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Kenneth Paul Hagen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,838 shares@ US$21.7575.8% of flowCommon StockSEC:0001638599-17-000872:0
- 3,802 shares0Common StockSEC:0001638599-17-000185:0
- 3,036 shares@ US$14.8224.2% of flowCommon StockSEC:0001638599-16-001081:0
3 of 3 declarations